| Announce Date | 10/29/2025 | 
| EPS Normalized Actual | $0.37 (Miss by $-0.2) | 
| EPS GAAP Actual | $0.37 (Miss by $-0.2) | 
| Revenue Actual | $25.2906B | 
| Revenue Surprise | Beat by $25290.6M | 
| Announce Date | 12/31/1969 (Pre-Market) | 
| EPS Normalized Estimate | $ | 
| EPS GAAP Estimate | $ | 
| Revenue Estimate | $0B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2029 | 3.5894 | 6.65 | 2.82665 | 3.93851 | 2 | 
| Dec 2028 | 3.0375 | 7.86 | 1.94095 | 3.67929 | 4 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.5 | 0.5 | 25.2906B | -0.68% | 25290.6M | 
| FQ1 2025 (Mar 2025) | 0 | 0 | 29.384B | 14.62% | 29384M | 
| FQ4 2024 (Dec 2024) | 0.73 | 0.73 | 26.535B | -8.7% | 26535M | 
| FQ3 2024 (Sep 2024) | 0.83 | 0.83 | 25.416B | -2% | 25416M | 
| FQ2 2024 (Jun 2024) | 0.65 | 0.65 | 25.462B | 10.18% | 25462M | 
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 25.089B | -16.43% | 25089M | 
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 28.843B | -17.33% | 28843M | 
| FQ3 2023 (Sep 2023) | 0.84 | 0.84 | 25.924B | -64.81% | 25924M | 
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.8146 | -- | 0.70243 | 0.89304 | 1 | 
| FQ3 2028 (Sep 2028) | 0.7599 | -- | 0.65527 | 0.83308 | 1 | 
| FQ2 2028 (Jun 2028) | 0.7689 | -- | 0.66303 | 0.84294 | 1 | 
| FQ1 2028 (Mar 2028) | 0.7674 | -- | 0.66173 | 0.8413 | 1 | 
| FQ4 2027 (Dec 2027) | 0.82577 | -- | 0.71207 | 0.90529 | 1 | 
| FQ3 2027 (Sep 2027) | 0.76305 | -- | 0.65798 | 0.83653 | 1 | 
| FQ2 2027 (Jun 2027) | 0.76463 | -- | 0.65935 | 0.83826 | 1 | 
| FQ1 2027 (Mar 2027) | 0.70444 | -- | 0.69337 | 0.71551 | 0 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 452.41B | -- | 404.49B | 485.92B | 1 | 
| FQ3 2028 (Sep 2028) | 421.78B | -- | 377.1B | 453.02B | 1 | 
| FQ2 2028 (Jun 2028) | 393.21B | -- | 351.57B | 422.34B | 1 | 
| FQ1 2028 (Mar 2028) | 366.59B | -- | 327.76B | 393.74B | 1 | 
| FQ4 2027 (Dec 2027) | 27.84B | -- | 24.89B | 29.9B | 1 | 
| FQ3 2027 (Sep 2027) | 27.65B | -- | 24.72B | 29.69B | 1 | 
| FQ2 2027 (Jun 2027) | 27.69B | -- | 24.76B | 29.75B | 1 | 
| FQ1 2027 (Mar 2027) | 48.68B | -- | 48.09B | 49.27B | 0 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.5 | 0.5 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | 0.73 | 0.73 | 100% | |
| FQ3 2024 (Sep 2024) | 0.83 | 0.83 | 100% | |
| FQ2 2024 (Jun 2024) | 0.65 | 0.65 | 100% | |
| FQ1 2024 (Mar 2024) | 0.91 | 0.91 | 100% | |
| FQ4 2023 (Dec 2023) | 0.88 | 0.88 | 100% | |
| FQ3 2023 (Sep 2023) | 0.84 | 0.84 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $25.29B | $25290.6M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $29.38B | $29384M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $26.54B | $26535M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $25.42B | $25416M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $25.46B | $25462M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $25.09B | $25089M | 100% | 
| FQ4 2023 (Dec 2023) | $0B | $28.84B | $28843M | 100% | 
| FQ3 2023 (Sep 2023) | $0B | $25.92B | $25924M | 100% |